Long-term efficacy of lurasidone in antipsychotic-naive vs. antipsychotic-exposed adolescents with schizophrenia: Post-hoc analysis of a two year, open-label study

被引：0

作者：

Correll, C. ^{[1
,2
]}

Goldman, R. ^{[3
]}

Tocco, M. ^{[4
]}

Pikalov, A. ^{[5
]}

Loebel, A. ^{[4
]}

机构：

[1] Zucker Hillside Hosp, Hofstra Northwell Sch Med, Glen Oaks, NY USA

[2] Charite, Psychiat Mol Biol & Child & Adolescent Psychiat, Berlin, Germany

[3] Sunovion Pharmaceut Inc, Res & Dev, Marlborough, MA USA

[4] Sunovion Pharmaceut Inc, Med Affairs, Marlborough, MA USA

[5] Sunovion Pharmaceut Inc, Med Affairs, Ft Lee, NJ USA

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷

关键词：

D O I：

10.1016/j.euroneuro.2019.09.157

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P.102

引用

页码：S88 / S88

页数：1

共 50 条

[1] LONG-TERM EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VERSUS ANTIPSYCHOTIC-EXPOSED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY
Correll, Christoph U.
Goldman, Robert S.
Tocco, Michael
Pikalov, Andrei A.
Hsu, Jay
Loebel, Antony
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S236 - S236
[2] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VS. PREVIOUSLY TREATED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A TWO YEAR, OPEN-LABEL STUDY
Correll, C. U.
Tocco, M.
Pikalov, A.
Goldman, R.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 102 - 102
[3] Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naive versus previously treated adolescents with Schizophrenia: A post-hoc analysis
Correll, Christoph U.
Tocco, Michael
Pikalov, Andrei
Hsu, Jay
Goldman, Robert
SCHIZOPHRENIA RESEARCH, 2022, 240 : 205 - 213
[4] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VERSUS PREVIOUSLY TREATED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY
Correll, C. U.
Tocco, M.
Goldman, R.
Pikalov, A.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (1_SUPPL): : 206 - 206
[5] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VS. PREVIOUSLY TREATED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY
Correll, C. U.
Tocco, M.
Pikalov, A.
Goldman, R.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 103 - 103
[6] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY
Correll, Christoph
Goldman, Robert
Tocco, Michael
Pikalov, Andrei
Hsu, Jay
Loebel, Antony
SCHIZOPHRENIA BULLETIN, 2019, 45 : S293 - S294
[7] One-year open-label study of the cognitive efficacy of blonanserin in antipsychotic-naive first-episode schizophrenia
Miyamoto, S.
Tenjin, T.
Miyake, N.
Ojima, K.
Ninomiya, Y.
Kitajima, R.
Ogino, S.
Kaneda, Y.
Sumiyoshi, T.
Yamaguchi, N.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 57 - 58
[8] Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study
Ishigooka, Jun
Inada, Ken
Niidome, Kazunari
Aoki, Kazuo
Kojima, Yoshitsugu
Iwashita, Shuichi
Yamada, Sakiko
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (04)
[9] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
Correll, C.
Goldman, R.
Tocco, M.
Pikalov, A.
Deng, L.
Loebel, A.
Coghill, D.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
[10] EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A TWO-YEAR OPEN-LABEL EXTENSION STUDY
Goldman, Robert S.
Tocco, Michael
Pikalov, Andrei A.
Deng, Ling
Loebel, Antony
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S160 - S160

← 1 2 3 4 5 →